Morgan Keegan Leaves VCA Antech $18 PT, Market Perform Rating Unchanged (WOOF)

Morgan Keegan left its VCA Antech WOOF $18 price target and Market Perform rating unchanged in a research report published today. In the report, Morgan Keegan states, "Long term we expect VCA Antech to maintain strong internal growth for its scalable veterinary lab business and internal growth augmented by accretive acquisitions for its animal hospitals. We believe that veterinary services are underpenetrated, providing the company with long-term growth opportunities. The weak economy creates a near-term impediment to growth prospects." Shares of VCA Antech were at $23.10 in after hours trading, up 0.35% from Friday's market close.